Human iPSC-derived Alzheimer's disease model
ioGABAergic Neurons APP V717I/V717I are opti-ox deterministically programmed GABAergic neurons, also known as inhibitory interneurons, carrying a genetically engineered homozygous V7171 (London) mutation in the APP gene encoding the amyloid precursor protein. This mutation is linked to familial early-onset Alzheimer's disease (AD).
These cells offer a functional, rapidly maturing, and disease relevant system in inhibitory neurons to study the role of the APP V717I (London) mutation in early-onset AD, alongside a genetically matched wild-type control.
Two clones are available, all genetically matched to the wild type control (ioGABAergic Neurons). The disease model cells and the wild-type control offer a physiologically relevant model to investigate the impact of the APP V717I mutation on cellular and molecular mechanisms and function in early-onset AD.
Applications: Alzheimer's disease modelling, Drug discovery and development, MEA analysis, Co-culture studies, ASO screening